Printer Friendly, PDF & Email

The top healthcare FCA developments of 2020

Michael E. Shaheen (mshaheen@crowell.com) is a Partner, Matthew P. Vicinanzo (mvicinanzo@crowell.com) and Payal Nanavati (pnanavati@crowell.com) are Associates in the Washington, DC, office of Crowell & Moring LLP.

Just as with all other aspects of life, the COVID-19 global pandemic had a dramatic effect on False Claims Act (FCA) enforcement in 2020. Whether it was the driving factor behind the formation of COVID-19 fraud task forces in US attorneys’ offices across the country or the reason that the Department of Justice (DOJ) investigations stalled for months, the heavy foot of COVID-19 left a sizable imprint on the FCA landscape. Nevertheless, the FCA and its warriors soldiered on with key developments, including several large-dollar settlements and significant rulings from courts across the country. This article highlights these and other top FCA developments in the healthcare space and looks ahead to what is in store for providers and payers in 2021.

This document is only available to members. Please log in or become a member.